PRLD vs TEL · rev $6.5M vs P/E 39, rev $17.26B
Prelude Therapeutics Inc (PRLD) versus TE Connectivity Ltd (TEL) — a side-by-side from cached financials, not a winner call.
Prelude Therapeutics Inc (PRLD) is a biotechnology company listed on NASDAQ.
TE Connectivity Ltd (TEL) is a electronic components company listed on US.
Latest reported PRLD revenue for 2025-09-30 was $6.5M. Net income was -$83.0M. Revenue was up 116.7% from 2024-09-30 to 2025-09-30. PRLD currently screens at market cap $346.5M.
Latest reported TEL revenue for 2025-09-26 was $17.26B. Net income was $1.84B. Revenue was up 8.9% from 2024-09-27 to 2025-09-26. TEL currently screens at market cap $52.52B and trailing P/E 38.5.
PRLD currently screens at market cap $346.5M. TEL currently screens at market cap $52.52B and trailing P/E 38.5.
Not investment advice. Open the PRLD and TEL stock pages for the full models.
Not investment advice.